Sexual Activity–Related Outcomes After Human Papillomavirus Vaccination of 11- to 12-Year-Olds
Top Cited Papers
Open Access
- 1 November 2012
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 130 (5) , 798-805
- https://doi.org/10.1542/peds.2012-1516
Abstract
OBJECTIVE: Previous surveys on hypothesized sexual activity changes after human papillomavirus (HPV) vaccination may be subject to self-response biases. To date, no studies measured clinical markers of sexual activity after HPV vaccination. This study evaluated sexual activity–related clinical outcomes after adolescent vaccination. METHODS: We conducted a retrospective cohort study utilizing longitudinal electronic data from a large managed care organization. Girls enrolled in the managed care organization, aged 11 through 12 years between July 2006 and December 2007, were classified by adolescent vaccine (HPV; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis, adsorbed; quadrivalent meningococcal conjugate) receipt. Outcomes (pregnancy/sexually transmitted infection testing or diagnosis; contraceptive counseling) were assessed through December 31, 2010, providing up to 3 years of follow-up. Incidence rate ratios comparing vaccination categories were estimated with multivariate Poisson regression, adjusting for health care–seeking behavior and demographic characteristics. RESULTS: The cohort included 1398 girls (493 HPV vaccine–exposed; 905 HPV vaccine–unexposed). Risk of the composite outcome (any pregnancy/sexually transmitted infection testing or diagnosis or contraceptive counseling) was not significantly elevated in HPV vaccine–exposed girls relative to HPV vaccine–unexposed girls (adjusted incidence rate ratio: 1.29, 95% confidence interval [CI]: 0.92 to1.80; incidence rate difference: 1.6/100 person-years; 95% CI: −0.03 to 3.24). Incidence rate difference for Chlamydia infection (0.06/100 person-years [95% CI: −0.30 to 0.18]) and pregnancy diagnoses (0.07/100 person-years [95% CI: −0.20 to 0.35]), indicating little clinically meaningful absolute risk differences. CONCLUSIONS: HPV vaccination in the recommended ages was not associated with increased sexual activity–related outcome rates.Keywords
This publication has 23 references indexed in Scilit:
- Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: Findings from the 2006–2008 National Survey of Family GrowthVaccine, 2012
- Human Papillomavirus Vaccine Intent and Uptake Among Female College StudentsJournal of American College Health, 2012
- HPV vaccine decision making in pediatric primary care: a semi-structured interview studyBMC Pediatrics, 2011
- Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003–2006The Journal of Infectious Diseases, 2011
- Factors Associated with Intention to Vaccinate a Daughter against HPV: A Statewide Survey in AlabamaJournal of Pediatric and Adolescent Gynecology, 2011
- Human papillomavirus vaccine uptake and barriers: Association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010Vaccine, 2011
- Human papillomavirus vaccine and behavioural disinhibitionSexually Transmitted Infections, 2011
- Passport to Promiscuity or Lifesaver: Press Coverage of HPV Vaccination and Risky Sexual BehaviorJournal of Health Communication, 2010
- Mothers' Intention for Their Daughters and Themselves to Receive the Human Papillomavirus Vaccine: A National Study of NursesPediatrics, 2009
- Mothers' Attitudes towards Preventing Cervical Cancer through Human Papillomavirus Vaccination: A Qualitative StudyCancer Epidemiology, Biomarkers & Prevention, 2006